How should I evaluate and manage a patient presenting with postprandial epigastric pain, bloating, early satiety, and mucus in the stool?

Evaluation and Management of Postprandial Epigastric Pain with Bloating and Mucus in Stool

This patient most likely has functional dyspepsia (FD), potentially overlapping with irritable bowel syndrome (IBS), and should be managed with a positive diagnosis approach without requiring endoscopy if they are under 55 years old and lack alarm features, followed by Helicobacter pylori testing and empiric treatment. 1

Initial Diagnostic Approach

Age-Based Risk Stratification

The first critical decision point is the patient's age:

• Under 55 years without alarm symptoms: Proceed directly to non-invasive H. pylori testing ("test and treat") without endoscopy 1
• Age 55+ with weight loss: Urgent endoscopy required 1
• Age 55+ with treatment-resistant dyspepsia, nausea/vomiting, or raised platelet count: Non-urgent endoscopy 1
• Age 60+ with abdominal pain AND weight loss: Consider urgent CT scan to exclude pancreatic cancer 1

Symptom Duration and Pattern

The diagnosis requires symptoms present for >8 weeks (though Rome IV technically requires 3 months with onset 6 months prior) 1. The key symptoms that define FD are:

• Bothersome epigastric pain or burning
• Early satiation
• Postprandial fullness

The presence of mucus in stools suggests overlapping IBS features, which is common and affects approximately 50% of FD patients 2.

Essential Baseline Investigations

Regardless of age, obtain:

1. Full blood count (especially if age ≥55) 1
2. Coeliac serology - mandatory when IBS-type symptoms overlap (which mucus in stool suggests) 1, 2
3. C-reactive protein or ESR 2
4. H. pylori testing (non-invasive: stool antigen or urea breath test) 1
5. Faecal calprotectin if diarrhoea present and age <45 years 2

Important caveat: Do NOT perform endoscopy reflexively. Approximately 80% of patients with dyspepsia will have FD after endoscopy, making it a low-yield investigation in the absence of risk factors 1.

Making the Positive Diagnosis

Establish FD as a disorder of gut-brain interaction, not a diagnosis of exclusion 1. In the absence of alarm features, the presence of postprandial epigastric pain, bloating, and fullness for >8 weeks IS the diagnosis. The mucus in stool indicates FD-IBS overlap, which is extremely common and does not require additional investigation beyond coeliac serology 1, 2.

Alarm Features to Exclude (Box 1 criteria):

• Dysphagia (any age)
• Weight loss with objective evidence
• Haematemesis or melaena
• Progressive unintentional weight loss
• Persistent vomiting
• Iron deficiency anaemia
• Palpable abdominal mass

Treatment Algorithm

Step 1: Patient Education and Lifestyle (Foundation)

Spend 2 minutes actively listening - this alone improves quality of life and reduces healthcare utilization 2. Explain:

• FD is a real disorder of gut-brain interaction, not psychological
• The gut-brain axis and how diet, stress, and emotional responses trigger symptoms
• Natural history: symptoms fluctuate but the condition is benign
• No cure exists, but quality of life can be substantially improved 1

Step 2: H. pylori Eradication (If Positive)

If H. pylori testing is positive, eradicate first before other treatments 1. This is the only potentially curative intervention.

Step 3: First-Line Pharmacotherapy

For postprandial symptoms (fullness, bloating, early satiety):

• Prokinetics (e.g., levosulpiride where available) 3

For epigastric pain/burning:

• Proton pump inhibitors (PPIs) for 4-8 weeks 1, 3

For the overlap presentation (this patient):

• Start with PPI trial given the epigastric pain component
• Consider adding prokinetic if inadequate response 3, 4

Step 4: Second-Line Options (If Refractory)

• Tricyclic antidepressants (neuromodulators) - effective for visceral pain 3, 4
• Atypical antipsychotics (levosulpiride) - dual benefit as prokinetic 3
• Phytotherapy: STW5 or peppermint/caraway oil (evidence-based alternatives) 3

Step 5: Addressing IBS Component

For the mucus in stool and likely IBS overlap:

• Antispasmodics for cramping
• Dietary modification (consider low FODMAP if bloating prominent)
• Probiotics may be considered 4

Critical Pitfalls to Avoid

1. Don't over-investigate: Endoscopy in young patients without alarm features wastes resources and delays effective treatment 1

2. Don't dismiss the diagnosis: FD affects 7-20% of the population and significantly impacts quality of life 1, 5. Validating the diagnosis is therapeutic.

3. Don't ignore the overlap: The presence of mucus in stool indicates IBS features - this requires coeliac serology and may need IBS-directed therapy 1, 2

4. Don't forget objective weight loss assessment: Patients frequently report weight loss subjectively, but objective documentation is essential before triggering urgent investigation 1

5. Don't use "functional" pejoratively: Frame this as a disorder of gut-brain interaction, not a psychological problem 1

Managing Expectations

Set realistic goals with the patient:

• Symptom improvement, not cure
• Treatment is often long-term
• Trial-and-error approach may be necessary
• Quality of life improvement is the primary outcome 1

Arrange follow-up to assess treatment response and adjust therapy accordingly, reinforcing that this is a manageable chronic condition requiring partnership between clinician and patient 1, 2.